(3R,3'R,4'S)-1'-(6-Amino-5-fluoropyrimidin-4-yl)-3-((3-chloro-5-(trifluoromethyl)phenyl)amino)-2-oxo-[1,3'-bipiperidine]-4'-carboxamide
(R)-3-(1-(1-Acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-N-(4-isopropyl-3-methylphenyl)benzamide
N-(1-(((R)-1-Acryloylpyrrolidin-2-yl)methyl)-5-((((S)-3,3-dimethylbutan-2-yl)amino)methyl)-1H-benzo[d]imidazol-2-yl)-5-(difluoromethyl)thiophene-2-carboxamide
BI-1622
GNE-9822
ITK inhibitor 5
4-((1H-Imidazol-4-yl)methyl)piperidine dihydrobromide
trans-4-((4-Benzyl-6-((6-ethylbenzo[d]thiazol-2-yl)amino)pyrimidin-2-yl)amino)cyclohexan-1-ol
ITK/TRKA-IN-1
ITK inhibitor 6
Gne-4997
Bms-509744
ITK degrader 2
EGFR-IN-40
(S)-N-(5-(((3,3-Dimethylbutan-2-yl)amino)methyl)-1-(2-hydroxy-2-methylpropyl)-1H-benzo[d]imidazol-2-yl)-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide
(S)-N-(2-(6,6-Dimethyl-4,5,6,7-tetrahydro-1H-indazol-3-yl)-1H-indol-6-yl)-N-methyl-2-morpholinopropanamide
